FDA advisory committees
This article was originally published in Pharmaceutical Approvals Monthly
Agency is requesting nominations for non-voting industry representatives to sit on existing Center for Biologics Evaluation & Research and Center for Drug Evaluation & Research advisory committees. Under the FDA Modernization Act, industry representation is required only for newly formed committees. However, FDA said it would add non-voting representatives to existing committees "to keep within the spirit of FDAMA
You may also be interested in...
Belgium’s UCB Pharma is expecting progress with new candidates for myasthenia gravis, psoriasis and osteoporosis this year.
A detailed report published by Medicines for Europe setting out policies affecting the off-patent industry across 22 European countries demonstrates the urgent need for pricing and reimbursement and procurement reforms, the association insists.
The Swiss major, which is already signed up to help produce Pfizer and BioNTech's COVID-19 vaccine, is offering its services to CureVac to produce its mRNA vaccine.